EGFR and ductal breast carcinoma in situ: Thus, it can be anticipated that during DCIS, grade 2 and grade 3, the isoform switches from canonical to cub isoform where the cells need to proliferate cancer growth via EGFR signalling pathway and the pathway is upregulated by the indirect activation of TACE by GPCR agonists.